LABA/ICS vs LAMA
Pneumonia: low‐risk population · chronic obstructive pulmonary disease with predicted FEV1 of less than 80%
LABA/ICS showed no clear difference in pneumonia: low‐risk population compared with LAMA (low certainty).
1 finding from 1 review
- Dual combination therapy versus long‐acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a… 2018 · Cochrane Headline outcomes onlyOR 5.82 [0.7, 48.8]2 studies · 885 participantsLow